How many mls is one dose of Mounjaro — and why does it matter?

Fixed volume, variable concentration: every Mounjaro dose delivers 0.5 ml; the amount of tirzepatide per ml rises at each strength.
One pen, four doses: the KwikPen holds 2 ml in total and is designed for four weekly 0.5 ml injections, a single month of treatment.
The volume does not confirm the dose: you cannot tell which strength you are using from the volume alone; the dose is set by the concentration of the solution inside the pen.
Injection site and technique matter independently of volume: abdomen, thigh and upper arm are all licensed sites; rotation helps avoid local reactions.

Each dose of Mounjaro is 0.5 ml, regardless of which strength you are on. From the 2.5 mg starter pen right through to 15 mg, the volume injected stays the same — what changes between doses is the concentration of tirzepatide dissolved in that half-millilitre. This is a question our prescribers hear most weeks, usually from people who want to double-check the pen is working or who are switching from another injectable medicine and expect the volume to scale with the dose. It doesn't. As a prescription-only medicine, Mounjaro must be prescribed following a clinical assessment, the volume detail here is drawn from the Summary of Product Characteristics published on the Medicines.org.uk Electronic Medicines Compendium (eMC), and confirmed in the NHS tirzepatide information pages.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The volume behind each Mounjaro strength, from 2.5 mg to 15 mg

What the Mounjaro SmPC actually says about dose volume

The Mounjaro SmPC, the formal prescribing document reviewed by the MHRA and available in full on the eMC, states that each dose is delivered as a 0.5 ml subcutaneous injection. This holds true across all six licensed UK strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg. The KwikPen itself holds 2 ml of solution, calibrated to release exactly 0.5 ml per actuation, giving four doses per pen. The pen's fixed-dose mechanism means there is no dial to adjust and no way to accidentally deliver more or less than 0.5 ml, which is one reason the KwikPen design was chosen for this treatment. If you ever look at the pen window after an injection and see the plunger has moved a quarter of the way down, that is exactly right. Four injections, four quarter-movements, pen complete. The eMC SmPC listing is the primary reference for storage, disposal and missed-dose guidance too; always check it alongside the patient information leaflet included in your box.

Why the volume stays fixed while the dose strength changes

The practical reason for a constant 0.5 ml volume is consistency of injection experience. A very small volume (say 0.1 ml) can be uncomfortable to deliver accurately into subcutaneous tissue, while a larger volume increases the chance of local reactions. Novo Nordisk and Eli Lilly, the two major manufacturers in this class, both landed on volumes in the 0.5–1.0 ml range for their respective injectable medicines. For Mounjaro specifically, Eli Lilly achieved the full strength range by increasing concentration rather than volume. At 2.5 mg the solution contains 5 mg/ml; at 15 mg it contains 30 mg/ml. The pen you hold looks and feels almost identical at every strength. If you are curious about what to expect from the 5 mg Mounjaro pen compared with the starter, the difference is in how your body responds over the following days, not in what you see at the injection site. A separate question many people ask alongside this one is how many doses are in each pen, four, always four, because the 2 ml total volume divides evenly into four 0.5 ml doses.

Reading the pen window: what 0.5 ml looks like in practice

The Mounjaro KwikPen has a small inspection window so you can see the solution before you inject. The liquid should be clear to slightly yellow with no visible particles. When you press the injection button and hold it for the full ten seconds (per the leaflet instructions), the plunger advances by 0.5 ml. Some people worry that the volume looks small or that they have missed part of the dose. If the plunger has moved and the ten-second hold was maintained, the dose has been delivered correctly. You can read a more detailed breakdown of the volume at the 2.5 mg starting strength in our guide to how many mls are in a 2.5 mg Mounjaro dose. For those wondering whether the answer differs in any way by strength, our page on Mounjaro dose volumes in general covers the same ground with slightly different framing. The short answer remains: 0.5 ml, every time, every strength. If the pen feels like it has not fired correctly, contact your prescriber before the next injection rather than attempting a repeat dose. Storage and technique queries, including how to handle the pen if it has been left out of the fridge, are best directed to your patient information leaflet or our FAQs.

What the volume question does not tell you about your treatment

Knowing the volume is genuinely useful for checking the pen and understanding why a 15 mg injection does not feel physically larger than a 2.5 mg one. What it cannot tell you is which strength is right for you. Prescribing decisions are based on how you have tolerated previous doses, your weight history, any relevant health conditions and how your body has responded so far. That clinical picture, not the number on the pen cap, drives titration. The SURMOUNT-1 trial, published in the New England Journal of Medicine, showed average body-weight reductions of around 20–21% at the 15 mg dose over 72 weeks, but those results were achieved through a medically supervised titration process, not by jumping straight to the highest strength. If you are at an early dose and wondering about the longer journey ahead, our overview of Mounjaro for weight management explains the full picture, and the concept of a 'golden dose' explores why many people find their sweet spot well before 15 mg. For cost context, the Mounjaro price comparison page sets out what private treatment typically costs across the strength range in the UK. Mounjaro is a prescription-only medicine; what strength you start or move to is a decision for your prescriber. If you'd like that clinical review, you can start your free consultation and a GPhC-registered prescriber will go through your history the same day.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions